July 09, 2015
A Massachusetts federal judge has unsealed four whistleblower complaints accusing Biogen Inc. of violating the False Claims Act by paying millions of dollars in kickbacks to doctors as incentives and rewards for prescribing the company's pricey multiple sclerosis drugs to Medicare patients.